These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4923004)

  • 1. Weight as a correlate of clinical response to psychotropic drugs.
    Singh MM; De Dios LV; Kline NS
    Psychosomatics; 1970; 11(6):562-70. PubMed ID: 4923004
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 3. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 4. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of some psychoactive drugs on mineral metabolism in man.
    Lovett Doust JW; Huszka L
    Int Pharmacopsychiatry; 1973; 8(3):159-72. PubMed ID: 4154924
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients.
    Young JP; Lader MH; Hughes WC
    Br Med J; 1979 Nov; 2(6201):1315-7. PubMed ID: 391342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observations on reserpine reversal after prolonged MAO inhibition.
    Esser AH
    Psychiatr Neurol Neurochir; 1967; 70(1):59-63. PubMed ID: 5339995
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 12. Weight changes with schizophrenic psychosis and psychotropic drug therapy.
    Holden JM; Holden UP
    Psychosomatics; 1970; 11(6):551-61. PubMed ID: 4923003
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke resulting from a rapid switch from phenelzine to tranylcypromine.
    Mattes JA
    J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269
    [No Abstract]   [Full Text] [Related]  

  • 14. Mood and sleep changes with monoamine-oxidase inhibitors.
    Dunleavy DL
    Proc R Soc Med; 1973 Sep; 66(9):951. PubMed ID: 4375816
    [No Abstract]   [Full Text] [Related]  

  • 15. Agranulocytosis and phenothiazines.
    Mandel A; Gross M
    Dis Nerv Syst; 1968 Jan; 29(1):32-6. PubMed ID: 5635744
    [No Abstract]   [Full Text] [Related]  

  • 16. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.
    Spiegel DE; Keith-Spiegel P
    J Nerv Ment Dis; 1967 Feb; 144(2):111-6. PubMed ID: 5338760
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
    Wyatt RJ; Fram DH; Buchbinder R; Snyder F
    N Engl J Med; 1971 Oct; 285(18):987-91. PubMed ID: 4328710
    [No Abstract]   [Full Text] [Related]  

  • 20. Tricyclic antidepressants and monoamine oxidase inhibitors.
    Schuckit M; Robins E; Feighner J
    Arch Gen Psychiatry; 1971 Jun; 24(6):509-14. PubMed ID: 5578096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.